山东大学耳鼻喉眼学报 ›› 2024, Vol. 38 ›› Issue (3): 18-25.doi: 10.6040/j.issn.1673-3770.0.2022.219

• 论著 • 上一篇    

异常纺锤体样小头畸形相关蛋白在鼻咽癌中的表达及其临床意义

杨开炎1, 唐凤珠2, 覃启才1, 李旭祥3, 冯大益3, 农丰靖1, 杨秋云1   

  1. 1.百色市人民医院 耳鼻咽喉头颈外科, 广西 百色 533000;
    2.广西壮族自治区人民医院 耳鼻咽喉头颈外科, 广西 南宁 530000;
    3.百色市人民医院 病理科, 广西 百色 533000
  • 发布日期:2024-06-04
  • 通讯作者: 唐凤珠. E-mail:1960491231@qq.com

Expression of abnormal spindle-like microcephaly associated protein in nasopharyngeal carcinoma and its clinical significance

YANG Kaiyan1, TANG Fengzhu2, QIN Qicai1, LI Xuxiang3, FENG Dayi3, NONG Fengjing1, YANG Qiuyun1   

  1. 1. Department of Otorhinolaryngology & Head and Neck Surgery, People's Hospital of Baise, Baise 533000, Guangxi, China2. Department of Otorhinolaryngology & Head and Neck Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530000, Guangxi, China3. Department of Pathology, People's Hospital of Baise, Baise 533000, Guangxi, China
  • Published:2024-06-04

PDF (PC)

34

摘要： 目的 通过免疫组化染色的方法研究异常纺锤体样小头畸形相关蛋白(abnormal spindle-like microcephaly associated protein, ASPM)在鼻咽癌组织样本中的表达情况,进一步分析ASPM蛋白表达与鼻咽癌患者临床病理参数和预后的关系,探讨ASPM mRNA在鼻咽癌中的表达情况。 方法 从GEO数据库下载鼻咽癌的芯片数据集,使用R语言对鼻咽癌芯片数据集进行差异表达分析;使用免疫组化染色方法分析ASPM蛋白在鼻咽癌中的差异表达;使用卡方检验的方法分析ASPM表达与鼻咽癌患者临床病理参数的相关性;采用生存曲线分析ASPM表达与鼻咽癌患者预后的关系;采用Cox回归模型分析影响鼻咽癌患者预后的危险因素;使用受试者工作特征(receiver operator characteristic, ROC)曲线评估各种预后参数预测鼻咽癌患者预后的效能。 结果 通过鼻咽癌芯片数据分析发现ASPM mRNA在鼻咽癌芯片数据集中高表达(P<0.001);免疫组化染色结果显示鼻咽癌组织中ASPM蛋白表达明显高于鼻咽炎组织(P<0.001),ASPM表达与T分期(P=0.048)、N分期(P=0.050)及总临床分期(P=0.029)相关,高表达ASPM蛋白组患者总生存期短于低表达ASPM蛋白组患者(P<0.001);通过多因素Cox回归模型分析,显示ASPM表达水平可能为影响鼻咽癌患者预后的独立危险因素(P=0.015);通过ROC曲线分析,显示联合总临床分期及ASPM表达用于预测鼻咽癌患者预后具有更高的准确性(P<0.001)。 结论 ASPM在鼻咽癌组织样本中高表达,其高表达与鼻咽癌的恶性程度、疾病进展及较差的预后相关,可能成为鼻咽癌中有价值的预测预后的生物标志物。联合总临床分期及ASPM表达用于预测鼻咽癌患者预后可能是一种有前景的方法。

关键词: 鼻咽癌, 免疫组化, 肿瘤预后, 异常纺锤体样小头畸形相关蛋白, 差异表达

Abstract: Objective This paper investigated the expression of abnormal spindle-like microcephaly associated protein(ASPM)in nasopharyngeal carcinoma tissue samples using immunohistochemical staining, and further analyzed the relationship between ASPM protein expression and clinicopathological parameters and the prognosis of patients with nasopharyngeal carcinoma, and then discussed the expression of ASPM mRNA in nasopharyngeal carcinoma. Methods The microarray dataset of nasopharyngeal carcinoma was downloaded from the GEO database, and the differential expression of the nasopharyngeal carcinoma microarray dataset was analyzed using R language. The differential expression of ASPM protein in nasopharyngeal carcinoma was analyzed using immunohistochemical staining, the correlation between ASPM expression and clinicopathological parameters of patients with nasopharyngeal carcinoma was analyzed using the chi-square test, the relationship between ASPM expression and prognosis of patients with nasopharyngeal carcinoma was analyzed by survival curves, the risk factors affecting prognosis of patients with nasopharyngeal carcinoma were analyzed using the Cox regression model, and the receiver operator characteristic(ROC)curve was used to evaluate the performance of various prognostic parameters in predicting the prognosis of patients with nasopharyngeal carcinoma. Results ASPM mRNA was found to be highly expressed in nasopharyngeal carcinoma microarray data set through analysis of nasopharyngeal carcinoma microarray data(P<0.001). Immunohistochemical staining showed that expression of ASPM in nasopharyngeal carcinoma tissues was significantly higher than in nasopharyngitis tissues(P<0.001). ASPM expression correlated with T stage(P=0.048), N stage(P=0.050), and total clinical stage(P=0.029). The overall survival time of the high expression ASPM protein group was shorter than that of the low expression ASPM protein group(P<0.001). Multivariate Cox regression model analysis showed that ASPM expression level may be an independent risk factor affecting prognosis of patients with nasopharyngeal carcinoma(P=0.015). ROC curve analysis showed that total clinical stage combined with ASPM expression achieved a higher accuracy in predicting prognosis of patients with nasopharyngeal carcinoma(P<0.001). Conclusion ASPM is highly expressed in nasopharyngeal carcinoma tissue samples, and this high expression is related to malignancy, disease progression, and poor prognosis of nasopharyngeal carcinoma, and may become a valuable biomarker for predicting prognosis in nasopharyngeal carcinoma. Combining total clinical stage and ASPM expression may be a promising method for predicting prognosis of patients with nasopharyngeal carcinoma.

Key words: Nasopharyngeal carcinoma, Immunohistochemistry, Tumor prognosis, Abnormal spindle-like microcephaly associated protein, Differential expression

中图分类号: 

  • R766.3
[1] Wei WI, Sham JS. Nasopharyngeal carcinoma[J]. Lancet, 2005, 365(9476): 2041-2054. doi:10.1016/s0140-6736(05)66698-6
[2] 范黎, 黎越, 徐细明. 鼻咽癌同步放化疗前后炎性指标变化及预测价值[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 36-41. doi: 10.6040/j.issn.1673-3770.0.2020.053 FAN Li, LI Yue, XU Ximing. Changes in and prognostic value of the inflammatory index before and after concurrent chemoradiotherapy for nasopharyngeal carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 36-41. doi: 10.6040/j.issn.1673-3770.0.2020.053
[3] Wu CC, Fang CY, Hsu HY, et al. EBV reactivation as a target of luteolin to repress NPC tumorigenesis[J]. Oncotarget, 2016, 7(14): 18999-19017. doi:10.18632/oncotarget.7967
[4] Kouprina N, Pavlicek A, Collins NK, et al. The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein[J]. Hum Mol Genet, 2005, 14(15): 2155-2165. doi:10.1093/hmg/ddi220
[5] Zeng WJ, Cheng Q, Wen ZP, et al. Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas[J]. J Cell Mol Med, 2020, 24(17): 9613-9626. doi:10.1111/jcmm.15435
[6] 张锐, 沈雅芳, 安肖霞, 等. 人类异常纺锤体样小头畸形相关蛋白在非小细胞肺癌中的表达及其临床意义[J]. 中华危重症医学杂志(电子版), 2020, 13(3): 176-180. doi:10.3877/cma.j.issn.1674-6880.2020.03.004 ZHANG Rui, SHEN Yafang, AN Xiaoxia, et al. Expression of abnormal spindle-like microcephaly associated protein in non-small cell lung cancer and its clinical significance[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2020, 13(3): 176-180. doi:10.3877/cma.j.issn.1674-6880.2020.03.004
[7] Davis S, Meltzer PS. GEOquery: a bridge between the gene expression omnibus(GEO)and BioConductor[J]. Bioinformatics, 2007, 23(14): 1846-1847. doi:10.1093/bioinformatics/btm254
[8] Ritchie ME, Phipson B, Wu D, et al. Limma Powers differential expression analyses for RNA-sequencing and microarray studies[J]. Nucleic Acids Res, 2015, 43(7): 47. doi:10.1093/nar/gkv007
[9] Liu YH, Li XN, Zhang YW, et al. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma[J]. Biomed Pharmacother, 2021, 143: 112096. doi:10.1016/j.biopha.2021.112096
[10] Adham M, Kurniawan AN, Muhtadi AI, et al. Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation[J]. Chin J Cancer, 2012, 31(4): 185-196. doi:10.5732/cjc.011.10328
[11] Cabral de Carvalho Corrêa D, Dias Oliveira I, Mascaro Cordeiro B, et al. Abnormal spindle-like microcephaly-associated(ASPM)gene expression in posterior Fossa brain tumors of childhood and adolescence[J]. Childs Nerv Syst, 2021, 37(1): 137-145. doi:10.1007/s00381-020-04740-1
[12] Wang F, Li J, Liu J, et al. Controversial role of the possible oxyntic stem cell marker ASPM in gastric cancer[J]. J Pathol, 2017, 241(4): 559-561. doi:10.1002/path.4863
[13] Pai VC, Hsu CC, Chan TS, et al. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling[J]. Oncogene, 2019, 38(8): 1340-1353. doi:10.1038/s41388-018-0497-4
[14] Wu YG, You YJ, Chen L, et al. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer[J]. Gland Surg, 2022, 11(4): 687-701. doi:10.21037/gs-22-29
[15] 陈悦康, 王伟, 卢启海, 等. ASPM基因在肾透明细胞癌中的表达及其诊断预后的价值[J]. 临床泌尿外科杂志, 2020, 35(5): 398-402. doi:10.13201/j.issn.1001-1420.2020.05.015 CHEN Yuekang, WANG Wei, LU Qihai, et al. Expression and prognostic value of ASPM in renal clear cell carcinoma[J]. Journal of Clinical Urology, 2020, 35(5): 398-402. doi:10.13201/j.issn.1001-1420.2020.05.015
[16] 吕珊妹, 徐文杰, 王艺臻, 等. ASPM基因在乳腺癌中的表达及临床意义[J]. 医学研究杂志, 2020, 49(4): 93-99. doi:10.11969/j.issn.1673-548X.2020.04.020 LYU Shanmei, XU Wenjie, WANG Yizhen, et al. Expression of ASPM in breast cancer and its clinical significance[J]. Journal of Medical Research, 2020, 49(4): 93-99. doi:10.11969/j.issn.1673-548X.2020.04.020
[17] Feng ZX, Zhang J, Zheng YF, et al. Overexpression of abnormal spindle-like microcephaly-associated(ASPM)increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma[J]. Transl Cancer Res, 2021, 10(2): 983-997. doi:10.21037/tcr-20-2570
[18] 季家祥, 赵扬, 齐晓杰, 等. ASPM在肝癌中的表达及其与肝癌肝移植预后的关系[J]. 中华器官移植杂志, 2021, 42(7): 408-412. doi:10.3760/cma.j.cn421203-20200423-00132 JI Jiaxiang, ZHAO Yang, QI Xiaojie, et al. Expression of abnormal spindle-likemicrocephaly-associated in hepatocellular carcinoma and its prognostic relationship after liver transplantation for hepatocellular carcinoma[J]. Chinese Journal of Organ Transplantation, 2021, 42(7): 408-412. doi:10.3760/cma.j.cn421203-20200423-00132
[19] 王俊杰, 何振宇, 段仁慧. ASPM在肺腺癌中的表达及其与肺腺癌的进展和预后关系的研究[J]. 中国肺癌杂志, 2020, 23(1): 29-35. doi:10.3779/j.issn.1009-3419.2020.01.05 WANG Junjie, HE Zhenyu, DUAN Renhui. Expression of ASPM in lung adenocarcinoma and its relationship with development and prognosis[J]. Chinese Journal of Lung Cancer, 2020, 23(1): 29-35. doi:10.3779/j.issn.1009-3419.2020.01.05
[20] Gao ZY, Yu F, Jia HX, et al. ASPM predicts poor prognosis and regulates cell proliferation in bladder cancer[J]. Kaohsiung J Med Sci, 2020, 36(12): 1021-1029. doi:10.1002/kjm2.12284
[21] Chan WL, Chow JCH, Xu ZY, et al. Management of nasopharyngeal carcinoma in elderly patients[J]. Front Oncol, 2022, 12: 810690. doi:10.3389/fonc.2022.810690
[22] Zeng Q, Xiang YQ, Wu PH, et al. A matched cohort study of standard chemo-radiotherapy versus radiotherapy alone in elderly nasopharyngeal carcinoma patients[J]. PLoS One, 2015, 10(3): 0119593. doi:10.1371/journal.pone.0119593
[23] Verma V, Surkar SM, Moreno AC, et al. Practice patterns and outcomes of chemoradiotherapy versus radiotherapy alone for older patients with nasopharyngeal cancer[J]. Cancer Med, 2018, 7(5): 1604-1611. doi:10.1002/cam4.1290
[24] Chiang CL, Guo QJ, Ng WT, et al. Prognostic factors for overall survival in nasopharyngeal cancer and implication for TNM staging by UICC: a systematic review of the literature[J]. Front Oncol, 2021, 11: 703995. doi:10.3389/fonc.2021.703995
[25] LI Jianpei, CHEN Shulin, PENG Songguo, et al. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics[J]. Int J Biol Sci, 2018, 14(5):549-556. doi: 10.7150/ijbs.24374
[26] Guo R, Mao YP, Tang LL, et al. The evolution of nasopharyngeal carcinoma staging[J]. Br J Radiol, 2019, 92(1102): 20190244. doi:10.1259/bjr.20190244
[1] 王靖淞,余灿,张西,邓启成,谢卓良,赵锐,温蓓,刘海. KRT4在喉癌及癌旁正常黏膜组织中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 12-17.
[2] 代红磊,王秋阳,马文学,官兵,齐静静. 基于Joinpoint回归及年龄-时期-队列模型分析鼻咽癌患者的死亡率发展趋势[J]. 山东大学耳鼻喉眼学报, 2024, 38(1): 27-31.
[3] 涂巧铃,李玉凤,彭军. 鼻咽癌中抗PD-L1/PD-1治疗及非编码RNA调控研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 135-141.
[4] 侯凌霄,展长翠,许安廷,范新泰,王娜. 鼻黏膜组织CD4+ T细胞参与季节性变应性鼻炎发病机制的生物信息学分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(4): 96-104.
[5] 刘佳钰,樊慧明,邹游,陈始明. 人工智能在鼻咽癌诊断与治疗中的应用研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 135-142.
[6] 任佳,吕丹,张银,孙佳莉,马兰,郑义涛,杨济民, 于凌昱,李波. 吞咽生命质量量表联合纤维内镜下吞咽功能检查技术在鼻咽癌放化疗后吞咽障碍患者中的应用[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 83-88.
[7] 程瑶,张震,杨吉,冯成敏,邓启成,张西,赵锐,朱鑫,吴俊志,刘海,邓世山. CIP2A在下咽癌中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 40-44.
[8] 华红利,李松，陶泽璋. 人工智能在鼻咽癌诊疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 113-119.
[9] 周宇翔,,苗北平,卢永田. 首诊鼻咽癌内镜手术的治疗进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 108-112.
[10] 冯成敏,敬一丹,刘海,王冰. 咽喉部鳞状细胞癌细胞系[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 113-124.
[11] 齐雯雯,陈鲁秋,贾涛,陈雪梅,张杰,张皓,金鹏,张虎. 复发性喉乳头状瘤中潜在生物学标志物的筛选及生物信息学分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(5): 75-84.
[12] 王中卫,杨林,郭亚,孙斌,王亚利,马秀龙,任宏涛,包兴. 鼻咽癌患者miR-429、miR-200C表达与预后关系分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(3): 81-86.
[13] 谭玉芳,易天华. 鼻咽癌放疗后突发性聋18例[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 35-39.
[14] 范黎,黎越,徐细明. 鼻咽癌同步放化疗前后炎性指标变化及预测价值[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 36-41.
[15] 董诗坤,沈宇杰,张立庆,周涵,张佳程,董伟达. 鉴定头颈部鳞癌中异常甲基化的差异表达基因及其通路[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 82-91.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发